There are several steps that health care providers can take to assure this approach is possible: (1) arrange for rapid processing of 25-hydroxyvitamin D \[25(OH)D\] and serum calcium specimens; (2) gain approval from the hospital pharmacy and therapeutics committee to stock 5,000 IU vitamin D capsules; (3) identify key staff physicians to provide consultative expertise in the rapid repletion of vitamin D in septic patients; (4) identify key pharmacists who can support provider and nursing education as well as patient specific therapeutic efforts; (5) identify key nurses to educate staff in the ER, ICU and ward settings; (6) consider notifying providers of vitamin D status, if known, at the time antibiotics or anti-viral agents are ordered; (7) correlate mortality data with vitamin D status in hospital-wide, blinded, non-judgmental communications; (8) correlate cost and length of stay data with vitamin D status in patients with infections; (9) consider addressing vitamin D status in patients at the time of scheduling for elective surgeries.

Capsules of 50,000 IU vitamin D~3~ are available (e.g., Biotech Pharmacal) and can be given to patients with very low serum 25-hydroxyvitamin D concentrations.

Self-education is available at vitamindcouncil.com. Vitamin D conferences have been available at several sites in North America and Europe.

Having practiced as a family physician for 25 y using the standard vitamin D dose of 400 IU and five years using vitamin D dosing sufficient to give blood levels \> 50 ng/ml (\> 120 nmoles/ml), I will never return to the "inky dinky dose" again.

Previously published online: [www.landesbioscience.com/journals/dermatoendocrinology/article/20272](http://www.landesbioscience.com/journals/dermatoendocrinology/article/20272/)
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